Global Non-opioid Pain Patch Market Growth 2025-2031
The global Non-opioid Pain Patch market size is predicted to grow from US$ 685 million in 2025 to US$ 803 million in 2031; it is expected to grow at a CAGR of 2.7% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
A non-opioid pain patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.
United States market for Non-opioid Pain Patch is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Non-opioid Pain Patch is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Non-opioid Pain Patch is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Non-opioid Pain Patch players cover Hisamitsu, Mylan, Johnson & Johnson, Actavis, Lingrui, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the ?Non-opioid Pain Patch Industry Forecast? looks at past sales and reviews total world Non-opioid Pain Patch sales in 2024, providing a comprehensive analysis by region and market sector of projected Non-opioid Pain Patch sales for 2025 through 2031. With Non-opioid Pain Patch sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-opioid Pain Patch industry.
This Insight Report provides a comprehensive analysis of the global Non-opioid Pain Patch landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-opioid Pain Patch portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Non-opioid Pain Patch market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-opioid Pain Patch and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-opioid Pain Patch.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-opioid Pain Patch market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Non-opioid Pain Patch market?
What factors are driving Non-opioid Pain Patch market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Non-opioid Pain Patch market opportunities vary by end market size?
How does Non-opioid Pain Patch break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
A non-opioid pain patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.
United States market for Non-opioid Pain Patch is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Non-opioid Pain Patch is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Non-opioid Pain Patch is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Non-opioid Pain Patch players cover Hisamitsu, Mylan, Johnson & Johnson, Actavis, Lingrui, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the ?Non-opioid Pain Patch Industry Forecast? looks at past sales and reviews total world Non-opioid Pain Patch sales in 2024, providing a comprehensive analysis by region and market sector of projected Non-opioid Pain Patch sales for 2025 through 2031. With Non-opioid Pain Patch sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-opioid Pain Patch industry.
This Insight Report provides a comprehensive analysis of the global Non-opioid Pain Patch landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-opioid Pain Patch portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Non-opioid Pain Patch market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-opioid Pain Patch and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-opioid Pain Patch.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-opioid Pain Patch market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Lidocaine Patches
- Diclofenac Patches
- Indomethacin Patches
- Counter-Irritant Patches
- Fentanyl Patches
- Others
- OTC
- Rx
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Hisamitsu
- Mylan
- Johnson & Johnson
- Actavis
- Lingrui
- Teikoku Seiyaku
- Sanofi
- Novartis
- Qizheng
- Endo
- Huarun 999
- GSK
- Haw Par
- Nichiban
- Mentholatum
- Laboratoires Genevrier
- BLUE-EMU
What is the 10-year outlook for the global Non-opioid Pain Patch market?
What factors are driving Non-opioid Pain Patch market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Non-opioid Pain Patch market opportunities vary by end market size?
How does Non-opioid Pain Patch break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-opioid Pain Patch Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Non-opioid Pain Patch by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Non-opioid Pain Patch by Country/Region, 2020, 2024 & 2031
2.2 Non-opioid Pain Patch Segment by Type
2.2.1 Lidocaine Patches
2.2.2 Diclofenac Patches
2.2.3 Indomethacin Patches
2.2.4 Counter-Irritant Patches
2.2.5 Fentanyl Patches
2.2.6 Others
2.3 Non-opioid Pain Patch Sales by Type
2.3.1 Global Non-opioid Pain Patch Sales Market Share by Type (2020-2025)
2.3.2 Global Non-opioid Pain Patch Revenue and Market Share by Type (2020-2025)
2.3.3 Global Non-opioid Pain Patch Sale Price by Type (2020-2025)
2.4 Non-opioid Pain Patch Segment by Application
2.4.1 OTC
2.4.2 Rx
2.5 Non-opioid Pain Patch Sales by Application
2.5.1 Global Non-opioid Pain Patch Sale Market Share by Application (2020-2025)
2.5.2 Global Non-opioid Pain Patch Revenue and Market Share by Application (2020-2025)
2.5.3 Global Non-opioid Pain Patch Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Non-opioid Pain Patch Breakdown Data by Company
3.1.1 Global Non-opioid Pain Patch Annual Sales by Company (2020-2025)
3.1.2 Global Non-opioid Pain Patch Sales Market Share by Company (2020-2025)
3.2 Global Non-opioid Pain Patch Annual Revenue by Company (2020-2025)
3.2.1 Global Non-opioid Pain Patch Revenue by Company (2020-2025)
3.2.2 Global Non-opioid Pain Patch Revenue Market Share by Company (2020-2025)
3.3 Global Non-opioid Pain Patch Sale Price by Company
3.4 Key Manufacturers Non-opioid Pain Patch Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-opioid Pain Patch Product Location Distribution
3.4.2 Players Non-opioid Pain Patch Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NON-OPIOID PAIN PATCH BY GEOGRAPHIC REGION
4.1 World Historic Non-opioid Pain Patch Market Size by Geographic Region (2020-2025)
4.1.1 Global Non-opioid Pain Patch Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Non-opioid Pain Patch Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Non-opioid Pain Patch Market Size by Country/Region (2020-2025)
4.2.1 Global Non-opioid Pain Patch Annual Sales by Country/Region (2020-2025)
4.2.2 Global Non-opioid Pain Patch Annual Revenue by Country/Region (2020-2025)
4.3 Americas Non-opioid Pain Patch Sales Growth
4.4 APAC Non-opioid Pain Patch Sales Growth
4.5 Europe Non-opioid Pain Patch Sales Growth
4.6 Middle East & Africa Non-opioid Pain Patch Sales Growth
5 AMERICAS
5.1 Americas Non-opioid Pain Patch Sales by Country
5.1.1 Americas Non-opioid Pain Patch Sales by Country (2020-2025)
5.1.2 Americas Non-opioid Pain Patch Revenue by Country (2020-2025)
5.2 Americas Non-opioid Pain Patch Sales by Type (2020-2025)
5.3 Americas Non-opioid Pain Patch Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-opioid Pain Patch Sales by Region
6.1.1 APAC Non-opioid Pain Patch Sales by Region (2020-2025)
6.1.2 APAC Non-opioid Pain Patch Revenue by Region (2020-2025)
6.2 APAC Non-opioid Pain Patch Sales by Type (2020-2025)
6.3 APAC Non-opioid Pain Patch Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Non-opioid Pain Patch by Country
7.1.1 Europe Non-opioid Pain Patch Sales by Country (2020-2025)
7.1.2 Europe Non-opioid Pain Patch Revenue by Country (2020-2025)
7.2 Europe Non-opioid Pain Patch Sales by Type (2020-2025)
7.3 Europe Non-opioid Pain Patch Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-opioid Pain Patch by Country
8.1.1 Middle East & Africa Non-opioid Pain Patch Sales by Country (2020-2025)
8.1.2 Middle East & Africa Non-opioid Pain Patch Revenue by Country (2020-2025)
8.2 Middle East & Africa Non-opioid Pain Patch Sales by Type (2020-2025)
8.3 Middle East & Africa Non-opioid Pain Patch Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-opioid Pain Patch
10.3 Manufacturing Process Analysis of Non-opioid Pain Patch
10.4 Industry Chain Structure of Non-opioid Pain Patch
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-opioid Pain Patch Distributors
11.3 Non-opioid Pain Patch Customer
12 WORLD FORECAST REVIEW FOR NON-OPIOID PAIN PATCH BY GEOGRAPHIC REGION
12.1 Global Non-opioid Pain Patch Market Size Forecast by Region
12.1.1 Global Non-opioid Pain Patch Forecast by Region (2026-2031)
12.1.2 Global Non-opioid Pain Patch Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Non-opioid Pain Patch Forecast by Type (2026-2031)
12.7 Global Non-opioid Pain Patch Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Hisamitsu
13.1.1 Hisamitsu Company Information
13.1.2 Hisamitsu Non-opioid Pain Patch Product Portfolios and Specifications
13.1.3 Hisamitsu Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Hisamitsu Main Business Overview
13.1.5 Hisamitsu Latest Developments
13.2 Mylan
13.2.1 Mylan Company Information
13.2.2 Mylan Non-opioid Pain Patch Product Portfolios and Specifications
13.2.3 Mylan Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Mylan Main Business Overview
13.2.5 Mylan Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson Non-opioid Pain Patch Product Portfolios and Specifications
13.3.3 Johnson & Johnson Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 Actavis
13.4.1 Actavis Company Information
13.4.2 Actavis Non-opioid Pain Patch Product Portfolios and Specifications
13.4.3 Actavis Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Actavis Main Business Overview
13.4.5 Actavis Latest Developments
13.5 Lingrui
13.5.1 Lingrui Company Information
13.5.2 Lingrui Non-opioid Pain Patch Product Portfolios and Specifications
13.5.3 Lingrui Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Lingrui Main Business Overview
13.5.5 Lingrui Latest Developments
13.6 Teikoku Seiyaku
13.6.1 Teikoku Seiyaku Company Information
13.6.2 Teikoku Seiyaku Non-opioid Pain Patch Product Portfolios and Specifications
13.6.3 Teikoku Seiyaku Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Teikoku Seiyaku Main Business Overview
13.6.5 Teikoku Seiyaku Latest Developments
13.7 Sanofi
13.7.1 Sanofi Company Information
13.7.2 Sanofi Non-opioid Pain Patch Product Portfolios and Specifications
13.7.3 Sanofi Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Sanofi Main Business Overview
13.7.5 Sanofi Latest Developments
13.8 Novartis
13.8.1 Novartis Company Information
13.8.2 Novartis Non-opioid Pain Patch Product Portfolios and Specifications
13.8.3 Novartis Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Novartis Main Business Overview
13.8.5 Novartis Latest Developments
13.9 Qizheng
13.9.1 Qizheng Company Information
13.9.2 Qizheng Non-opioid Pain Patch Product Portfolios and Specifications
13.9.3 Qizheng Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Qizheng Main Business Overview
13.9.5 Qizheng Latest Developments
13.10 Endo
13.10.1 Endo Company Information
13.10.2 Endo Non-opioid Pain Patch Product Portfolios and Specifications
13.10.3 Endo Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Endo Main Business Overview
13.10.5 Endo Latest Developments
13.11 Huarun 999
13.11.1 Huarun 999 Company Information
13.11.2 Huarun 999 Non-opioid Pain Patch Product Portfolios and Specifications
13.11.3 Huarun 999 Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Huarun 999 Main Business Overview
13.11.5 Huarun 999 Latest Developments
13.12 GSK
13.12.1 GSK Company Information
13.12.2 GSK Non-opioid Pain Patch Product Portfolios and Specifications
13.12.3 GSK Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 GSK Main Business Overview
13.12.5 GSK Latest Developments
13.13 Haw Par
13.13.1 Haw Par Company Information
13.13.2 Haw Par Non-opioid Pain Patch Product Portfolios and Specifications
13.13.3 Haw Par Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Haw Par Main Business Overview
13.13.5 Haw Par Latest Developments
13.14 Nichiban
13.14.1 Nichiban Company Information
13.14.2 Nichiban Non-opioid Pain Patch Product Portfolios and Specifications
13.14.3 Nichiban Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Nichiban Main Business Overview
13.14.5 Nichiban Latest Developments
13.15 Mentholatum
13.15.1 Mentholatum Company Information
13.15.2 Mentholatum Non-opioid Pain Patch Product Portfolios and Specifications
13.15.3 Mentholatum Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Mentholatum Main Business Overview
13.15.5 Mentholatum Latest Developments
13.16 Laboratoires Genevrier
13.16.1 Laboratoires Genevrier Company Information
13.16.2 Laboratoires Genevrier Non-opioid Pain Patch Product Portfolios and Specifications
13.16.3 Laboratoires Genevrier Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Laboratoires Genevrier Main Business Overview
13.16.5 Laboratoires Genevrier Latest Developments
13.17 BLUE-EMU
13.17.1 BLUE-EMU Company Information
13.17.2 BLUE-EMU Non-opioid Pain Patch Product Portfolios and Specifications
13.17.3 BLUE-EMU Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 BLUE-EMU Main Business Overview
13.17.5 BLUE-EMU Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-opioid Pain Patch Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Non-opioid Pain Patch by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Non-opioid Pain Patch by Country/Region, 2020, 2024 & 2031
2.2 Non-opioid Pain Patch Segment by Type
2.2.1 Lidocaine Patches
2.2.2 Diclofenac Patches
2.2.3 Indomethacin Patches
2.2.4 Counter-Irritant Patches
2.2.5 Fentanyl Patches
2.2.6 Others
2.3 Non-opioid Pain Patch Sales by Type
2.3.1 Global Non-opioid Pain Patch Sales Market Share by Type (2020-2025)
2.3.2 Global Non-opioid Pain Patch Revenue and Market Share by Type (2020-2025)
2.3.3 Global Non-opioid Pain Patch Sale Price by Type (2020-2025)
2.4 Non-opioid Pain Patch Segment by Application
2.4.1 OTC
2.4.2 Rx
2.5 Non-opioid Pain Patch Sales by Application
2.5.1 Global Non-opioid Pain Patch Sale Market Share by Application (2020-2025)
2.5.2 Global Non-opioid Pain Patch Revenue and Market Share by Application (2020-2025)
2.5.3 Global Non-opioid Pain Patch Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Non-opioid Pain Patch Breakdown Data by Company
3.1.1 Global Non-opioid Pain Patch Annual Sales by Company (2020-2025)
3.1.2 Global Non-opioid Pain Patch Sales Market Share by Company (2020-2025)
3.2 Global Non-opioid Pain Patch Annual Revenue by Company (2020-2025)
3.2.1 Global Non-opioid Pain Patch Revenue by Company (2020-2025)
3.2.2 Global Non-opioid Pain Patch Revenue Market Share by Company (2020-2025)
3.3 Global Non-opioid Pain Patch Sale Price by Company
3.4 Key Manufacturers Non-opioid Pain Patch Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-opioid Pain Patch Product Location Distribution
3.4.2 Players Non-opioid Pain Patch Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NON-OPIOID PAIN PATCH BY GEOGRAPHIC REGION
4.1 World Historic Non-opioid Pain Patch Market Size by Geographic Region (2020-2025)
4.1.1 Global Non-opioid Pain Patch Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Non-opioid Pain Patch Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Non-opioid Pain Patch Market Size by Country/Region (2020-2025)
4.2.1 Global Non-opioid Pain Patch Annual Sales by Country/Region (2020-2025)
4.2.2 Global Non-opioid Pain Patch Annual Revenue by Country/Region (2020-2025)
4.3 Americas Non-opioid Pain Patch Sales Growth
4.4 APAC Non-opioid Pain Patch Sales Growth
4.5 Europe Non-opioid Pain Patch Sales Growth
4.6 Middle East & Africa Non-opioid Pain Patch Sales Growth
5 AMERICAS
5.1 Americas Non-opioid Pain Patch Sales by Country
5.1.1 Americas Non-opioid Pain Patch Sales by Country (2020-2025)
5.1.2 Americas Non-opioid Pain Patch Revenue by Country (2020-2025)
5.2 Americas Non-opioid Pain Patch Sales by Type (2020-2025)
5.3 Americas Non-opioid Pain Patch Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-opioid Pain Patch Sales by Region
6.1.1 APAC Non-opioid Pain Patch Sales by Region (2020-2025)
6.1.2 APAC Non-opioid Pain Patch Revenue by Region (2020-2025)
6.2 APAC Non-opioid Pain Patch Sales by Type (2020-2025)
6.3 APAC Non-opioid Pain Patch Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Non-opioid Pain Patch by Country
7.1.1 Europe Non-opioid Pain Patch Sales by Country (2020-2025)
7.1.2 Europe Non-opioid Pain Patch Revenue by Country (2020-2025)
7.2 Europe Non-opioid Pain Patch Sales by Type (2020-2025)
7.3 Europe Non-opioid Pain Patch Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-opioid Pain Patch by Country
8.1.1 Middle East & Africa Non-opioid Pain Patch Sales by Country (2020-2025)
8.1.2 Middle East & Africa Non-opioid Pain Patch Revenue by Country (2020-2025)
8.2 Middle East & Africa Non-opioid Pain Patch Sales by Type (2020-2025)
8.3 Middle East & Africa Non-opioid Pain Patch Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-opioid Pain Patch
10.3 Manufacturing Process Analysis of Non-opioid Pain Patch
10.4 Industry Chain Structure of Non-opioid Pain Patch
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-opioid Pain Patch Distributors
11.3 Non-opioid Pain Patch Customer
12 WORLD FORECAST REVIEW FOR NON-OPIOID PAIN PATCH BY GEOGRAPHIC REGION
12.1 Global Non-opioid Pain Patch Market Size Forecast by Region
12.1.1 Global Non-opioid Pain Patch Forecast by Region (2026-2031)
12.1.2 Global Non-opioid Pain Patch Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Non-opioid Pain Patch Forecast by Type (2026-2031)
12.7 Global Non-opioid Pain Patch Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Hisamitsu
13.1.1 Hisamitsu Company Information
13.1.2 Hisamitsu Non-opioid Pain Patch Product Portfolios and Specifications
13.1.3 Hisamitsu Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Hisamitsu Main Business Overview
13.1.5 Hisamitsu Latest Developments
13.2 Mylan
13.2.1 Mylan Company Information
13.2.2 Mylan Non-opioid Pain Patch Product Portfolios and Specifications
13.2.3 Mylan Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Mylan Main Business Overview
13.2.5 Mylan Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson Non-opioid Pain Patch Product Portfolios and Specifications
13.3.3 Johnson & Johnson Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 Actavis
13.4.1 Actavis Company Information
13.4.2 Actavis Non-opioid Pain Patch Product Portfolios and Specifications
13.4.3 Actavis Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Actavis Main Business Overview
13.4.5 Actavis Latest Developments
13.5 Lingrui
13.5.1 Lingrui Company Information
13.5.2 Lingrui Non-opioid Pain Patch Product Portfolios and Specifications
13.5.3 Lingrui Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Lingrui Main Business Overview
13.5.5 Lingrui Latest Developments
13.6 Teikoku Seiyaku
13.6.1 Teikoku Seiyaku Company Information
13.6.2 Teikoku Seiyaku Non-opioid Pain Patch Product Portfolios and Specifications
13.6.3 Teikoku Seiyaku Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Teikoku Seiyaku Main Business Overview
13.6.5 Teikoku Seiyaku Latest Developments
13.7 Sanofi
13.7.1 Sanofi Company Information
13.7.2 Sanofi Non-opioid Pain Patch Product Portfolios and Specifications
13.7.3 Sanofi Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Sanofi Main Business Overview
13.7.5 Sanofi Latest Developments
13.8 Novartis
13.8.1 Novartis Company Information
13.8.2 Novartis Non-opioid Pain Patch Product Portfolios and Specifications
13.8.3 Novartis Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Novartis Main Business Overview
13.8.5 Novartis Latest Developments
13.9 Qizheng
13.9.1 Qizheng Company Information
13.9.2 Qizheng Non-opioid Pain Patch Product Portfolios and Specifications
13.9.3 Qizheng Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Qizheng Main Business Overview
13.9.5 Qizheng Latest Developments
13.10 Endo
13.10.1 Endo Company Information
13.10.2 Endo Non-opioid Pain Patch Product Portfolios and Specifications
13.10.3 Endo Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Endo Main Business Overview
13.10.5 Endo Latest Developments
13.11 Huarun 999
13.11.1 Huarun 999 Company Information
13.11.2 Huarun 999 Non-opioid Pain Patch Product Portfolios and Specifications
13.11.3 Huarun 999 Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Huarun 999 Main Business Overview
13.11.5 Huarun 999 Latest Developments
13.12 GSK
13.12.1 GSK Company Information
13.12.2 GSK Non-opioid Pain Patch Product Portfolios and Specifications
13.12.3 GSK Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 GSK Main Business Overview
13.12.5 GSK Latest Developments
13.13 Haw Par
13.13.1 Haw Par Company Information
13.13.2 Haw Par Non-opioid Pain Patch Product Portfolios and Specifications
13.13.3 Haw Par Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Haw Par Main Business Overview
13.13.5 Haw Par Latest Developments
13.14 Nichiban
13.14.1 Nichiban Company Information
13.14.2 Nichiban Non-opioid Pain Patch Product Portfolios and Specifications
13.14.3 Nichiban Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Nichiban Main Business Overview
13.14.5 Nichiban Latest Developments
13.15 Mentholatum
13.15.1 Mentholatum Company Information
13.15.2 Mentholatum Non-opioid Pain Patch Product Portfolios and Specifications
13.15.3 Mentholatum Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Mentholatum Main Business Overview
13.15.5 Mentholatum Latest Developments
13.16 Laboratoires Genevrier
13.16.1 Laboratoires Genevrier Company Information
13.16.2 Laboratoires Genevrier Non-opioid Pain Patch Product Portfolios and Specifications
13.16.3 Laboratoires Genevrier Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Laboratoires Genevrier Main Business Overview
13.16.5 Laboratoires Genevrier Latest Developments
13.17 BLUE-EMU
13.17.1 BLUE-EMU Company Information
13.17.2 BLUE-EMU Non-opioid Pain Patch Product Portfolios and Specifications
13.17.3 BLUE-EMU Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 BLUE-EMU Main Business Overview
13.17.5 BLUE-EMU Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Non-opioid Pain Patch Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Non-opioid Pain Patch Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Lidocaine Patches
Table 4. Major Players of Diclofenac Patches
Table 5. Major Players of Indomethacin Patches
Table 6. Major Players of Counter-Irritant Patches
Table 7. Major Players of Fentanyl Patches
Table 8. Major Players of Others
Table 9. Global Non-opioid Pain Patch Sales by Type (2020-2025) & (M Units)
Table 10. Global Non-opioid Pain Patch Sales Market Share by Type (2020-2025)
Table 11. Global Non-opioid Pain Patch Revenue by Type (2020-2025) & ($ million)
Table 12. Global Non-opioid Pain Patch Revenue Market Share by Type (2020-2025)
Table 13. Global Non-opioid Pain Patch Sale Price by Type (2020-2025) & (USD/K Units)
Table 14. Global Non-opioid Pain Patch Sale by Application (2020-2025) & (M Units)
Table 15. Global Non-opioid Pain Patch Sale Market Share by Application (2020-2025)
Table 16. Global Non-opioid Pain Patch Revenue by Application (2020-2025) & ($ million)
Table 17. Global Non-opioid Pain Patch Revenue Market Share by Application (2020-2025)
Table 18. Global Non-opioid Pain Patch Sale Price by Application (2020-2025) & (USD/K Units)
Table 19. Global Non-opioid Pain Patch Sales by Company (2020-2025) & (M Units)
Table 20. Global Non-opioid Pain Patch Sales Market Share by Company (2020-2025)
Table 21. Global Non-opioid Pain Patch Revenue by Company (2020-2025) & ($ millions)
Table 22. Global Non-opioid Pain Patch Revenue Market Share by Company (2020-2025)
Table 23. Global Non-opioid Pain Patch Sale Price by Company (2020-2025) & (USD/K Units)
Table 24. Key Manufacturers Non-opioid Pain Patch Producing Area Distribution and Sales Area
Table 25. Players Non-opioid Pain Patch Products Offered
Table 26. Non-opioid Pain Patch Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Non-opioid Pain Patch Sales by Geographic Region (2020-2025) & (M Units)
Table 30. Global Non-opioid Pain Patch Sales Market Share Geographic Region (2020-2025)
Table 31. Global Non-opioid Pain Patch Revenue by Geographic Region (2020-2025) & ($ millions)
Table 32. Global Non-opioid Pain Patch Revenue Market Share by Geographic Region (2020-2025)
Table 33. Global Non-opioid Pain Patch Sales by Country/Region (2020-2025) & (M Units)
Table 34. Global Non-opioid Pain Patch Sales Market Share by Country/Region (2020-2025)
Table 35. Global Non-opioid Pain Patch Revenue by Country/Region (2020-2025) & ($ millions)
Table 36. Global Non-opioid Pain Patch Revenue Market Share by Country/Region (2020-2025)
Table 37. Americas Non-opioid Pain Patch Sales by Country (2020-2025) & (M Units)
Table 38. Americas Non-opioid Pain Patch Sales Market Share by Country (2020-2025)
Table 39. Americas Non-opioid Pain Patch Revenue by Country (2020-2025) & ($ millions)
Table 40. Americas Non-opioid Pain Patch Sales by Type (2020-2025) & (M Units)
Table 41. Americas Non-opioid Pain Patch Sales by Application (2020-2025) & (M Units)
Table 42. APAC Non-opioid Pain Patch Sales by Region (2020-2025) & (M Units)
Table 43. APAC Non-opioid Pain Patch Sales Market Share by Region (2020-2025)
Table 44. APAC Non-opioid Pain Patch Revenue by Region (2020-2025) & ($ millions)
Table 45. APAC Non-opioid Pain Patch Sales by Type (2020-2025) & (M Units)
Table 46. APAC Non-opioid Pain Patch Sales by Application (2020-2025) & (M Units)
Table 47. Europe Non-opioid Pain Patch Sales by Country (2020-2025) & (M Units)
Table 48. Europe Non-opioid Pain Patch Revenue by Country (2020-2025) & ($ millions)
Table 49. Europe Non-opioid Pain Patch Sales by Type (2020-2025) & (M Units)
Table 50. Europe Non-opioid Pain Patch Sales by Application (2020-2025) & (M Units)
Table 51. Middle East & Africa Non-opioid Pain Patch Sales by Country (2020-2025) & (M Units)
Table 52. Middle East & Africa Non-opioid Pain Patch Revenue Market Share by Country (2020-2025)
Table 53. Middle East & Africa Non-opioid Pain Patch Sales by Type (2020-2025) & (M Units)
Table 54. Middle East & Africa Non-opioid Pain Patch Sales by Application (2020-2025) & (M Units)
Table 55. Key Market Drivers & Growth Opportunities of Non-opioid Pain Patch
Table 56. Key Market Challenges & Risks of Non-opioid Pain Patch
Table 57. Key Industry Trends of Non-opioid Pain Patch
Table 58. Non-opioid Pain Patch Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Non-opioid Pain Patch Distributors List
Table 61. Non-opioid Pain Patch Customer List
Table 62. Global Non-opioid Pain Patch Sales Forecast by Region (2026-2031) & (M Units)
Table 63. Global Non-opioid Pain Patch Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Americas Non-opioid Pain Patch Sales Forecast by Country (2026-2031) & (M Units)
Table 65. Americas Non-opioid Pain Patch Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. APAC Non-opioid Pain Patch Sales Forecast by Region (2026-2031) & (M Units)
Table 67. APAC Non-opioid Pain Patch Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 68. Europe Non-opioid Pain Patch Sales Forecast by Country (2026-2031) & (M Units)
Table 69. Europe Non-opioid Pain Patch Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Middle East & Africa Non-opioid Pain Patch Sales Forecast by Country (2026-2031) & (M Units)
Table 71. Middle East & Africa Non-opioid Pain Patch Revenue Forecast by Country (2026-2031) & ($ millions)
Table 72. Global Non-opioid Pain Patch Sales Forecast by Type (2026-2031) & (M Units)
Table 73. Global Non-opioid Pain Patch Revenue Forecast by Type (2026-2031) & ($ millions)
Table 74. Global Non-opioid Pain Patch Sales Forecast by Application (2026-2031) & (M Units)
Table 75. Global Non-opioid Pain Patch Revenue Forecast by Application (2026-2031) & ($ millions)
Table 76. Hisamitsu Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors
Table 77. Hisamitsu Non-opioid Pain Patch Product Portfolios and Specifications
Table 78. Hisamitsu Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 79. Hisamitsu Main Business
Table 80. Hisamitsu Latest Developments
Table 81. Mylan Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors
Table 82. Mylan Non-opioid Pain Patch Product Portfolios and Specifications
Table 83. Mylan Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 84. Mylan Main Business
Table 85. Mylan Latest Developments
Table 86. Johnson & Johnson Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors
Table 87. Johnson & Johnson Non-opioid Pain Patch Product Portfolios and Specifications
Table 88. Johnson & Johnson Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 89. Johnson & Johnson Main Business
Table 90. Johnson & Johnson Latest Developments
Table 91. Actavis Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors
Table 92. Actavis Non-opioid Pain Patch Product Portfolios and Specifications
Table 93. Actavis Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 94. Actavis Main Business
Table 95. Actavis Latest Developments
Table 96. Lingrui Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors
Table 97. Lingrui Non-opioid Pain Patch Product Portfolios and Specifications
Table 98. Lingrui Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 99. Lingrui Main Business
Table 100. Lingrui Latest Developments
Table 101. Teikoku Seiyaku Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors
Table 102. Teikoku Seiyaku Non-opioid Pain Patch Product Portfolios and Specifications
Table 103. Teikoku Seiyaku Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 104. Teikoku Seiyaku Main Business
Table 105. Teikoku Seiyaku Latest Developments
Table 106. Sanofi Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors
Table 107. Sanofi Non-opioid Pain Patch Product Portfolios and Specifications
Table 108. Sanofi Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 109. Sanofi Main Business
Table 110. Sanofi Latest Developments
Table 111. Novartis Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors
Table 112. Novartis Non-opioid Pain Patch Product Portfolios and Specifications
Table 113. Novartis Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 114. Novartis Main Business
Table 115. Novartis Latest Developments
Table 116. Qizheng Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors
Table 117. Qizheng Non-opioid Pain Patch Product Portfolios and Specifications
Table 118. Qizheng Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 119. Qizheng Main Business
Table 120. Qizheng Latest Developments
Table 121. Endo Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors
Table 122. Endo Non-opioid Pain Patch Product Portfolios and Specifications
Table 123. Endo Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 124. Endo Main Business
Table 125. Endo Latest Developments
Table 126. Huarun 999 Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors
Table 127. Huarun 999 Non-opioid Pain Patch Product Portfolios and Specifications
Table 128. Huarun 999 Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 129. Huarun 999 Main Business
Table 130. Huarun 999 Latest Developments
Table 131. GSK Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors
Table 132. GSK Non-opioid Pain Patch Product Portfolios and Specifications
Table 133. GSK Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 134. GSK Main Business
Table 135. GSK Latest Developments
Table 136. Haw Par Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors
Table 137. Haw Par Non-opioid Pain Patch Product Portfolios and Specifications
Table 138. Haw Par Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 139. Haw Par Main Business
Table 140. Haw Par Latest Developments
Table 141. Nichiban Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors
Table 142. Nichiban Non-opioid Pain Patch Product Portfolios and Specifications
Table 143. Nichiban Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 144. Nichiban Main Business
Table 145. Nichiban Latest Developments
Table 146. Mentholatum Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors
Table 147. Mentholatum Non-opioid Pain Patch Product Portfolios and Specifications
Table 148. Mentholatum Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 149. Mentholatum Main Business
Table 150. Mentholatum Latest Developments
Table 151. Laboratoires Genevrier Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors
Table 152. Laboratoires Genevrier Non-opioid Pain Patch Product Portfolios and Specifications
Table 153. Laboratoires Genevrier Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 154. Laboratoires Genevrier Main Business
Table 155. Laboratoires Genevrier Latest Developments
Table 156. BLUE-EMU Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors
Table 157. BLUE-EMU Non-opioid Pain Patch Product Portfolios and Specifications
Table 158. BLUE-EMU Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 159. BLUE-EMU Main Business
Table 160. BLUE-EMU Latest Developments
Table 1. Non-opioid Pain Patch Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Non-opioid Pain Patch Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Lidocaine Patches
Table 4. Major Players of Diclofenac Patches
Table 5. Major Players of Indomethacin Patches
Table 6. Major Players of Counter-Irritant Patches
Table 7. Major Players of Fentanyl Patches
Table 8. Major Players of Others
Table 9. Global Non-opioid Pain Patch Sales by Type (2020-2025) & (M Units)
Table 10. Global Non-opioid Pain Patch Sales Market Share by Type (2020-2025)
Table 11. Global Non-opioid Pain Patch Revenue by Type (2020-2025) & ($ million)
Table 12. Global Non-opioid Pain Patch Revenue Market Share by Type (2020-2025)
Table 13. Global Non-opioid Pain Patch Sale Price by Type (2020-2025) & (USD/K Units)
Table 14. Global Non-opioid Pain Patch Sale by Application (2020-2025) & (M Units)
Table 15. Global Non-opioid Pain Patch Sale Market Share by Application (2020-2025)
Table 16. Global Non-opioid Pain Patch Revenue by Application (2020-2025) & ($ million)
Table 17. Global Non-opioid Pain Patch Revenue Market Share by Application (2020-2025)
Table 18. Global Non-opioid Pain Patch Sale Price by Application (2020-2025) & (USD/K Units)
Table 19. Global Non-opioid Pain Patch Sales by Company (2020-2025) & (M Units)
Table 20. Global Non-opioid Pain Patch Sales Market Share by Company (2020-2025)
Table 21. Global Non-opioid Pain Patch Revenue by Company (2020-2025) & ($ millions)
Table 22. Global Non-opioid Pain Patch Revenue Market Share by Company (2020-2025)
Table 23. Global Non-opioid Pain Patch Sale Price by Company (2020-2025) & (USD/K Units)
Table 24. Key Manufacturers Non-opioid Pain Patch Producing Area Distribution and Sales Area
Table 25. Players Non-opioid Pain Patch Products Offered
Table 26. Non-opioid Pain Patch Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Non-opioid Pain Patch Sales by Geographic Region (2020-2025) & (M Units)
Table 30. Global Non-opioid Pain Patch Sales Market Share Geographic Region (2020-2025)
Table 31. Global Non-opioid Pain Patch Revenue by Geographic Region (2020-2025) & ($ millions)
Table 32. Global Non-opioid Pain Patch Revenue Market Share by Geographic Region (2020-2025)
Table 33. Global Non-opioid Pain Patch Sales by Country/Region (2020-2025) & (M Units)
Table 34. Global Non-opioid Pain Patch Sales Market Share by Country/Region (2020-2025)
Table 35. Global Non-opioid Pain Patch Revenue by Country/Region (2020-2025) & ($ millions)
Table 36. Global Non-opioid Pain Patch Revenue Market Share by Country/Region (2020-2025)
Table 37. Americas Non-opioid Pain Patch Sales by Country (2020-2025) & (M Units)
Table 38. Americas Non-opioid Pain Patch Sales Market Share by Country (2020-2025)
Table 39. Americas Non-opioid Pain Patch Revenue by Country (2020-2025) & ($ millions)
Table 40. Americas Non-opioid Pain Patch Sales by Type (2020-2025) & (M Units)
Table 41. Americas Non-opioid Pain Patch Sales by Application (2020-2025) & (M Units)
Table 42. APAC Non-opioid Pain Patch Sales by Region (2020-2025) & (M Units)
Table 43. APAC Non-opioid Pain Patch Sales Market Share by Region (2020-2025)
Table 44. APAC Non-opioid Pain Patch Revenue by Region (2020-2025) & ($ millions)
Table 45. APAC Non-opioid Pain Patch Sales by Type (2020-2025) & (M Units)
Table 46. APAC Non-opioid Pain Patch Sales by Application (2020-2025) & (M Units)
Table 47. Europe Non-opioid Pain Patch Sales by Country (2020-2025) & (M Units)
Table 48. Europe Non-opioid Pain Patch Revenue by Country (2020-2025) & ($ millions)
Table 49. Europe Non-opioid Pain Patch Sales by Type (2020-2025) & (M Units)
Table 50. Europe Non-opioid Pain Patch Sales by Application (2020-2025) & (M Units)
Table 51. Middle East & Africa Non-opioid Pain Patch Sales by Country (2020-2025) & (M Units)
Table 52. Middle East & Africa Non-opioid Pain Patch Revenue Market Share by Country (2020-2025)
Table 53. Middle East & Africa Non-opioid Pain Patch Sales by Type (2020-2025) & (M Units)
Table 54. Middle East & Africa Non-opioid Pain Patch Sales by Application (2020-2025) & (M Units)
Table 55. Key Market Drivers & Growth Opportunities of Non-opioid Pain Patch
Table 56. Key Market Challenges & Risks of Non-opioid Pain Patch
Table 57. Key Industry Trends of Non-opioid Pain Patch
Table 58. Non-opioid Pain Patch Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Non-opioid Pain Patch Distributors List
Table 61. Non-opioid Pain Patch Customer List
Table 62. Global Non-opioid Pain Patch Sales Forecast by Region (2026-2031) & (M Units)
Table 63. Global Non-opioid Pain Patch Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Americas Non-opioid Pain Patch Sales Forecast by Country (2026-2031) & (M Units)
Table 65. Americas Non-opioid Pain Patch Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. APAC Non-opioid Pain Patch Sales Forecast by Region (2026-2031) & (M Units)
Table 67. APAC Non-opioid Pain Patch Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 68. Europe Non-opioid Pain Patch Sales Forecast by Country (2026-2031) & (M Units)
Table 69. Europe Non-opioid Pain Patch Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Middle East & Africa Non-opioid Pain Patch Sales Forecast by Country (2026-2031) & (M Units)
Table 71. Middle East & Africa Non-opioid Pain Patch Revenue Forecast by Country (2026-2031) & ($ millions)
Table 72. Global Non-opioid Pain Patch Sales Forecast by Type (2026-2031) & (M Units)
Table 73. Global Non-opioid Pain Patch Revenue Forecast by Type (2026-2031) & ($ millions)
Table 74. Global Non-opioid Pain Patch Sales Forecast by Application (2026-2031) & (M Units)
Table 75. Global Non-opioid Pain Patch Revenue Forecast by Application (2026-2031) & ($ millions)
Table 76. Hisamitsu Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors
Table 77. Hisamitsu Non-opioid Pain Patch Product Portfolios and Specifications
Table 78. Hisamitsu Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 79. Hisamitsu Main Business
Table 80. Hisamitsu Latest Developments
Table 81. Mylan Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors
Table 82. Mylan Non-opioid Pain Patch Product Portfolios and Specifications
Table 83. Mylan Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 84. Mylan Main Business
Table 85. Mylan Latest Developments
Table 86. Johnson & Johnson Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors
Table 87. Johnson & Johnson Non-opioid Pain Patch Product Portfolios and Specifications
Table 88. Johnson & Johnson Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 89. Johnson & Johnson Main Business
Table 90. Johnson & Johnson Latest Developments
Table 91. Actavis Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors
Table 92. Actavis Non-opioid Pain Patch Product Portfolios and Specifications
Table 93. Actavis Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 94. Actavis Main Business
Table 95. Actavis Latest Developments
Table 96. Lingrui Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors
Table 97. Lingrui Non-opioid Pain Patch Product Portfolios and Specifications
Table 98. Lingrui Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 99. Lingrui Main Business
Table 100. Lingrui Latest Developments
Table 101. Teikoku Seiyaku Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors
Table 102. Teikoku Seiyaku Non-opioid Pain Patch Product Portfolios and Specifications
Table 103. Teikoku Seiyaku Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 104. Teikoku Seiyaku Main Business
Table 105. Teikoku Seiyaku Latest Developments
Table 106. Sanofi Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors
Table 107. Sanofi Non-opioid Pain Patch Product Portfolios and Specifications
Table 108. Sanofi Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 109. Sanofi Main Business
Table 110. Sanofi Latest Developments
Table 111. Novartis Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors
Table 112. Novartis Non-opioid Pain Patch Product Portfolios and Specifications
Table 113. Novartis Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 114. Novartis Main Business
Table 115. Novartis Latest Developments
Table 116. Qizheng Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors
Table 117. Qizheng Non-opioid Pain Patch Product Portfolios and Specifications
Table 118. Qizheng Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 119. Qizheng Main Business
Table 120. Qizheng Latest Developments
Table 121. Endo Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors
Table 122. Endo Non-opioid Pain Patch Product Portfolios and Specifications
Table 123. Endo Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 124. Endo Main Business
Table 125. Endo Latest Developments
Table 126. Huarun 999 Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors
Table 127. Huarun 999 Non-opioid Pain Patch Product Portfolios and Specifications
Table 128. Huarun 999 Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 129. Huarun 999 Main Business
Table 130. Huarun 999 Latest Developments
Table 131. GSK Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors
Table 132. GSK Non-opioid Pain Patch Product Portfolios and Specifications
Table 133. GSK Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 134. GSK Main Business
Table 135. GSK Latest Developments
Table 136. Haw Par Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors
Table 137. Haw Par Non-opioid Pain Patch Product Portfolios and Specifications
Table 138. Haw Par Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 139. Haw Par Main Business
Table 140. Haw Par Latest Developments
Table 141. Nichiban Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors
Table 142. Nichiban Non-opioid Pain Patch Product Portfolios and Specifications
Table 143. Nichiban Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 144. Nichiban Main Business
Table 145. Nichiban Latest Developments
Table 146. Mentholatum Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors
Table 147. Mentholatum Non-opioid Pain Patch Product Portfolios and Specifications
Table 148. Mentholatum Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 149. Mentholatum Main Business
Table 150. Mentholatum Latest Developments
Table 151. Laboratoires Genevrier Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors
Table 152. Laboratoires Genevrier Non-opioid Pain Patch Product Portfolios and Specifications
Table 153. Laboratoires Genevrier Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 154. Laboratoires Genevrier Main Business
Table 155. Laboratoires Genevrier Latest Developments
Table 156. BLUE-EMU Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors
Table 157. BLUE-EMU Non-opioid Pain Patch Product Portfolios and Specifications
Table 158. BLUE-EMU Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 159. BLUE-EMU Main Business
Table 160. BLUE-EMU Latest Developments
LIST OF FIGURES
Figure 1. Picture of Non-opioid Pain Patch
Figure 2. Non-opioid Pain Patch Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-opioid Pain Patch Sales Growth Rate 2020-2031 (M Units)
Figure 7. Global Non-opioid Pain Patch Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Non-opioid Pain Patch Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Non-opioid Pain Patch Sales Market Share by Country/Region (2024)
Figure 10. Non-opioid Pain Patch Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Lidocaine Patches
Figure 12. Product Picture of Diclofenac Patches
Figure 13. Product Picture of Indomethacin Patches
Figure 14. Product Picture of Counter-Irritant Patches
Figure 15. Product Picture of Fentanyl Patches
Figure 16. Product Picture of Others
Figure 17. Global Non-opioid Pain Patch Sales Market Share by Type in 2025
Figure 18. Global Non-opioid Pain Patch Revenue Market Share by Type (2020-2025)
Figure 19. Non-opioid Pain Patch Consumed in OTC
Figure 20. Global Non-opioid Pain Patch Market: OTC (2020-2025) & (M Units)
Figure 21. Non-opioid Pain Patch Consumed in Rx
Figure 22. Global Non-opioid Pain Patch Market: Rx (2020-2025) & (M Units)
Figure 23. Global Non-opioid Pain Patch Sale Market Share by Application (2024)
Figure 24. Global Non-opioid Pain Patch Revenue Market Share by Application in 2025
Figure 25. Non-opioid Pain Patch Sales by Company in 2025 (M Units)
Figure 26. Global Non-opioid Pain Patch Sales Market Share by Company in 2025
Figure 27. Non-opioid Pain Patch Revenue by Company in 2025 ($ millions)
Figure 28. Global Non-opioid Pain Patch Revenue Market Share by Company in 2025
Figure 29. Global Non-opioid Pain Patch Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Non-opioid Pain Patch Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Non-opioid Pain Patch Sales 2020-2025 (M Units)
Figure 32. Americas Non-opioid Pain Patch Revenue 2020-2025 ($ millions)
Figure 33. APAC Non-opioid Pain Patch Sales 2020-2025 (M Units)
Figure 34. APAC Non-opioid Pain Patch Revenue 2020-2025 ($ millions)
Figure 35. Europe Non-opioid Pain Patch Sales 2020-2025 (M Units)
Figure 36. Europe Non-opioid Pain Patch Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Non-opioid Pain Patch Sales 2020-2025 (M Units)
Figure 38. Middle East & Africa Non-opioid Pain Patch Revenue 2020-2025 ($ millions)
Figure 39. Americas Non-opioid Pain Patch Sales Market Share by Country in 2025
Figure 40. Americas Non-opioid Pain Patch Revenue Market Share by Country (2020-2025)
Figure 41. Americas Non-opioid Pain Patch Sales Market Share by Type (2020-2025)
Figure 42. Americas Non-opioid Pain Patch Sales Market Share by Application (2020-2025)
Figure 43. United States Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Non-opioid Pain Patch Sales Market Share by Region in 2025
Figure 48. APAC Non-opioid Pain Patch Revenue Market Share by Region (2020-2025)
Figure 49. APAC Non-opioid Pain Patch Sales Market Share by Type (2020-2025)
Figure 50. APAC Non-opioid Pain Patch Sales Market Share by Application (2020-2025)
Figure 51. China Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 55. India Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Non-opioid Pain Patch Sales Market Share by Country in 2025
Figure 59. Europe Non-opioid Pain Patch Revenue Market Share by Country (2020-2025)
Figure 60. Europe Non-opioid Pain Patch Sales Market Share by Type (2020-2025)
Figure 61. Europe Non-opioid Pain Patch Sales Market Share by Application (2020-2025)
Figure 62. Germany Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 63. France Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Non-opioid Pain Patch Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Non-opioid Pain Patch Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Non-opioid Pain Patch Sales Market Share by Application (2020-2025)
Figure 70. Egypt Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Non-opioid Pain Patch in 2025
Figure 76. Manufacturing Process Analysis of Non-opioid Pain Patch
Figure 77. Industry Chain Structure of Non-opioid Pain Patch
Figure 78. Channels of Distribution
Figure 79. Global Non-opioid Pain Patch Sales Market Forecast by Region (2026-2031)
Figure 80. Global Non-opioid Pain Patch Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Non-opioid Pain Patch Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Non-opioid Pain Patch Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Non-opioid Pain Patch Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Non-opioid Pain Patch Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Non-opioid Pain Patch
Figure 2. Non-opioid Pain Patch Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-opioid Pain Patch Sales Growth Rate 2020-2031 (M Units)
Figure 7. Global Non-opioid Pain Patch Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Non-opioid Pain Patch Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Non-opioid Pain Patch Sales Market Share by Country/Region (2024)
Figure 10. Non-opioid Pain Patch Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Lidocaine Patches
Figure 12. Product Picture of Diclofenac Patches
Figure 13. Product Picture of Indomethacin Patches
Figure 14. Product Picture of Counter-Irritant Patches
Figure 15. Product Picture of Fentanyl Patches
Figure 16. Product Picture of Others
Figure 17. Global Non-opioid Pain Patch Sales Market Share by Type in 2025
Figure 18. Global Non-opioid Pain Patch Revenue Market Share by Type (2020-2025)
Figure 19. Non-opioid Pain Patch Consumed in OTC
Figure 20. Global Non-opioid Pain Patch Market: OTC (2020-2025) & (M Units)
Figure 21. Non-opioid Pain Patch Consumed in Rx
Figure 22. Global Non-opioid Pain Patch Market: Rx (2020-2025) & (M Units)
Figure 23. Global Non-opioid Pain Patch Sale Market Share by Application (2024)
Figure 24. Global Non-opioid Pain Patch Revenue Market Share by Application in 2025
Figure 25. Non-opioid Pain Patch Sales by Company in 2025 (M Units)
Figure 26. Global Non-opioid Pain Patch Sales Market Share by Company in 2025
Figure 27. Non-opioid Pain Patch Revenue by Company in 2025 ($ millions)
Figure 28. Global Non-opioid Pain Patch Revenue Market Share by Company in 2025
Figure 29. Global Non-opioid Pain Patch Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Non-opioid Pain Patch Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Non-opioid Pain Patch Sales 2020-2025 (M Units)
Figure 32. Americas Non-opioid Pain Patch Revenue 2020-2025 ($ millions)
Figure 33. APAC Non-opioid Pain Patch Sales 2020-2025 (M Units)
Figure 34. APAC Non-opioid Pain Patch Revenue 2020-2025 ($ millions)
Figure 35. Europe Non-opioid Pain Patch Sales 2020-2025 (M Units)
Figure 36. Europe Non-opioid Pain Patch Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Non-opioid Pain Patch Sales 2020-2025 (M Units)
Figure 38. Middle East & Africa Non-opioid Pain Patch Revenue 2020-2025 ($ millions)
Figure 39. Americas Non-opioid Pain Patch Sales Market Share by Country in 2025
Figure 40. Americas Non-opioid Pain Patch Revenue Market Share by Country (2020-2025)
Figure 41. Americas Non-opioid Pain Patch Sales Market Share by Type (2020-2025)
Figure 42. Americas Non-opioid Pain Patch Sales Market Share by Application (2020-2025)
Figure 43. United States Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Non-opioid Pain Patch Sales Market Share by Region in 2025
Figure 48. APAC Non-opioid Pain Patch Revenue Market Share by Region (2020-2025)
Figure 49. APAC Non-opioid Pain Patch Sales Market Share by Type (2020-2025)
Figure 50. APAC Non-opioid Pain Patch Sales Market Share by Application (2020-2025)
Figure 51. China Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 55. India Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Non-opioid Pain Patch Sales Market Share by Country in 2025
Figure 59. Europe Non-opioid Pain Patch Revenue Market Share by Country (2020-2025)
Figure 60. Europe Non-opioid Pain Patch Sales Market Share by Type (2020-2025)
Figure 61. Europe Non-opioid Pain Patch Sales Market Share by Application (2020-2025)
Figure 62. Germany Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 63. France Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Non-opioid Pain Patch Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Non-opioid Pain Patch Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Non-opioid Pain Patch Sales Market Share by Application (2020-2025)
Figure 70. Egypt Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Non-opioid Pain Patch Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Non-opioid Pain Patch in 2025
Figure 76. Manufacturing Process Analysis of Non-opioid Pain Patch
Figure 77. Industry Chain Structure of Non-opioid Pain Patch
Figure 78. Channels of Distribution
Figure 79. Global Non-opioid Pain Patch Sales Market Forecast by Region (2026-2031)
Figure 80. Global Non-opioid Pain Patch Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Non-opioid Pain Patch Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Non-opioid Pain Patch Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Non-opioid Pain Patch Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Non-opioid Pain Patch Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Tibial Plateau Plates Market Growth 2025-2031
US$ 3,660.00
April 2025
100 pages
Global Smart Biosensor Market Growth 2024-2030
US$ 3,660.00
March 2024
117 pages
Global Cold & Freezer Rooms Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
November 2024
88 pages
Global Jet-Based Needle-Free Injectors Market Growth 2023-2029
US$ 3,660.00
February 2023
98 pages
Global Infusion Warmer Market Growth 2024-2030
US$ 3,660.00
March 2024
115 pages
